Theravance Biopharma
TBPH
#6421
Rank
A$1.32 B
Marketcap
Country
A$25.53
Share price
0.00%
Change (1 day)
-10.13%
Change (1 year)

EPS for Theravance Biopharma (TBPH)

EPS in 2026 (TTM): A$1.59

According to Theravance Biopharma 's latest financial reports the company's current EPS (TTM) is A$1.59. In 2025 the company made an earnings per share (EPS) of A$3.13 an increase over its 2024 EPS that were of A-$1.72.

EPS history for Theravance Biopharma from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.59-49.13%
2025A$3.13-281.74%
2024A-$1.7218.56%
2023A-$1.45-108.41%
2022A$17.30-491.19%
2021A-$4.42-34.15%
2020A-$6.725.16%
2019A-$6.396.5%
2018A-$6.00-26.61%
2017A-$8.1728.24%
2016A-$6.37
2014A-$11.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Corcept Therapeutics
CORT
A$2.25 41.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Collegium Pharmaceutical
COLL
A$1.83 15.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$2.71 70.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
A-$9.49-697.17%๐Ÿ‡บ๐Ÿ‡ธ USA